NASDAQ · Health care

Turn Therapeutics Inc. (TTRX)

It posted a net loss of $8.4M. At June 30, 2026 it held $9.9M in cash against $7.3M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Price

$12.49

-5.81% on the day · September 25, 2026

52-week range $2.57 to $26.50

Market cap

$372.1M

What Turn Therapeutics Inc. does

Turn Therapeutics Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker TTRX.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	-$5.9M	-$3.2M	-$0.12	n/a
2025	n/a	-$1.8M	-$1.8M	-$0.07	n/a

Next report expected around November 13, 2026.

Estimated from its filing rhythm: about 93 days after its last report of August 12, 2026, its usual gap. Not a date the company has announced. See the report calendar

Latest SEC filings

What Turn Therapeutics Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 10, 2026
Investor disclosure 8-K
September 9, 2026
Investor disclosure 8-K
August 18, 2026
Unregistered share sale 8-K
August 17, 2026
Investor disclosure 8-K
August 12, 2026
Quarterly report 10-Q · period to June 30, 2026
August 12, 2026
Quarterly results 8-K
July 28, 2026
Investor disclosure 8-K
July 7, 2026
Investor disclosure 8-K
June 3, 2026
Investor disclosure 8-K
June 1, 2026
Investor disclosure 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 8, 2026. Insider transactions on SEC

Insider trades

What the people running Turn Therapeutics Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about TTRX

What does Turn Therapeutics Inc. do?

Turn Therapeutics Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker TTRX.

Is Turn Therapeutics Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $8.4M.

When did Turn Therapeutics Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 10, 2026.

Similar companies

Compare TTRX with

Compare TTRX with any company

Follow TTRX

Get an email when Turn Therapeutics Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow TTRX: get an email when it files

Where the numbers come from

Financial figures are the values Turn Therapeutics Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.